ABSTRACT
In this chapter, the author explores what networks of care emerge in response to uneven access to high-quality antimalarials. She engages in the complexities surrounding the process of seeking a treatment for malaria in rural Tanzania and takes a closer look at how people have responded to a multitude of uncertainties; that is, shortages of Artemisinin-based Combination therapy (ACT), fake medicines, or high costs to cover antimalarial therapy. The author deals with the economic aspects of Artemisia therapy and, in so doing, with a central aspect of the question relating to the accessibility of antimalarial medicines. This involves first and foremost the socio-economic implications of the type of self-treatment propagated by ANAMED: local production of an antimalarial medicine. ANAMED's grassroots movements' attempt to organize humanitarian intervention using alternative methods for delivering artemisinin to patients represents a unique case in terms of access to therapeutic care.
